BackBackTotal revenue of Travere Therapeutics, Inc.
Annual data
2008
2009
2010
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
0.00
60.00 M
120.00 M
180.00 M
240.00 M
Period
Value
Change
Change %
TTM
233.18 M
0.00
0.00%
2024
233.18 M
+87.94 M
+60.55%
2023
145.24 M
+35.78 M
+32.69%
2022
109.46 M
−118.03 M
−51.88%
2021
227.49 M
+29.17 M
+14.71%
2020
198.32 M
+22.98 M
+13.11%
Quarterly data
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
20.00 M
40.00 M
60.00 M
80.00 M
Period
Value
Change
Change %
Q4 '24
74.79 M
+11.89 M
+18.90%
Q3 '24
62.90 M
+8.78 M
+16.23%
Q2 '24
54.12 M
+12.74 M
+30.80%
Q1 '24
41.37 M
−3.69 M
−8.18%
Q4 '23
45.06 M
+7.96 M
+21.47%
Q3 '23
37.09 M
−22.60 M
−37.86%
Q2 '23
59.70 M
+2.70 M
+4.74%
Q1 '23
56.99 M
+1.13 M
+2.01%